Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.

Serological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical severities. Potent humoral responses were detected within 3 weeks of onset of illness in all patients and the serological titre was eli...

Full description

Saved in:
Bibliographic Details
Main Authors: Kuan-Ying A Huang, Tiong Kit Tan, Ting-Hua Chen, Chung-Guei Huang, Ruth Harvey, Saira Hussain, Cheng-Pin Chen, Adam Harding, Javier Gilbert-Jaramillo, Xu Liu, Michael Knight, Lisa Schimanski, Shin-Ru Shih, Yi-Chun Lin, Chien-Yu Cheng, Shu-Hsing Cheng, Yhu-Chering Huang, Tzou-Yien Lin, Jia-Tsrong Jan, Che Ma, William James, Rodney S Daniels, John W McCauley, Pramila Rijal, Alain R Townsend
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-02-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009352&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850128471938826240
author Kuan-Ying A Huang
Tiong Kit Tan
Ting-Hua Chen
Chung-Guei Huang
Ruth Harvey
Saira Hussain
Cheng-Pin Chen
Adam Harding
Javier Gilbert-Jaramillo
Xu Liu
Michael Knight
Lisa Schimanski
Shin-Ru Shih
Yi-Chun Lin
Chien-Yu Cheng
Shu-Hsing Cheng
Yhu-Chering Huang
Tzou-Yien Lin
Jia-Tsrong Jan
Che Ma
William James
Rodney S Daniels
John W McCauley
Pramila Rijal
Alain R Townsend
author_facet Kuan-Ying A Huang
Tiong Kit Tan
Ting-Hua Chen
Chung-Guei Huang
Ruth Harvey
Saira Hussain
Cheng-Pin Chen
Adam Harding
Javier Gilbert-Jaramillo
Xu Liu
Michael Knight
Lisa Schimanski
Shin-Ru Shih
Yi-Chun Lin
Chien-Yu Cheng
Shu-Hsing Cheng
Yhu-Chering Huang
Tzou-Yien Lin
Jia-Tsrong Jan
Che Ma
William James
Rodney S Daniels
John W McCauley
Pramila Rijal
Alain R Townsend
author_sort Kuan-Ying A Huang
collection DOAJ
description Serological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical severities. Potent humoral responses were detected within 3 weeks of onset of illness in all patients and the serological titre was elicited soon after or concomitantly with peripheral plasmablast response. An average of 13.7% and 3.5% of plasmablast-derived MAbs were reactive with virus spike glycoprotein or nucleocapsid, respectively. A subset of anti-spike (10 of 32) antibodies cross-reacted with other betacoronaviruses tested and harboured extensive somatic mutations, indicative of an expansion of memory B cells upon SARS-CoV-2 infection. Fourteen of 32 anti-spike MAbs, including five anti-receptor-binding domain (RBD), three anti-non-RBD S1 and six anti-S2, neutralised wild-type SARS-CoV-2 in independent assays. Anti-RBD MAbs were further grouped into four cross-inhibiting clusters, of which six antibodies from three separate clusters blocked the binding of RBD to ACE2 and five were neutralising. All ACE2-blocking anti-RBD antibodies were isolated from two recovered patients with prolonged fever, which is compatible with substantial ACE2-blocking response in their sera. Finally, the identification of non-competing pairs of neutralising antibodies would offer potential templates for the development of prophylactic and therapeutic agents against SARS-CoV-2.
format Article
id doaj-art-7e9ce5b081804c2fbe263952aa0c1f4f
institution OA Journals
issn 1553-7366
1553-7374
language English
publishDate 2021-02-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-7e9ce5b081804c2fbe263952aa0c1f4f2025-08-20T02:33:18ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742021-02-01172e100935210.1371/journal.ppat.1009352Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.Kuan-Ying A HuangTiong Kit TanTing-Hua ChenChung-Guei HuangRuth HarveySaira HussainCheng-Pin ChenAdam HardingJavier Gilbert-JaramilloXu LiuMichael KnightLisa SchimanskiShin-Ru ShihYi-Chun LinChien-Yu ChengShu-Hsing ChengYhu-Chering HuangTzou-Yien LinJia-Tsrong JanChe MaWilliam JamesRodney S DanielsJohn W McCauleyPramila RijalAlain R TownsendSerological and plasmablast responses and plasmablast-derived IgG monoclonal antibodies (MAbs) have been analysed in three COVID-19 patients with different clinical severities. Potent humoral responses were detected within 3 weeks of onset of illness in all patients and the serological titre was elicited soon after or concomitantly with peripheral plasmablast response. An average of 13.7% and 3.5% of plasmablast-derived MAbs were reactive with virus spike glycoprotein or nucleocapsid, respectively. A subset of anti-spike (10 of 32) antibodies cross-reacted with other betacoronaviruses tested and harboured extensive somatic mutations, indicative of an expansion of memory B cells upon SARS-CoV-2 infection. Fourteen of 32 anti-spike MAbs, including five anti-receptor-binding domain (RBD), three anti-non-RBD S1 and six anti-S2, neutralised wild-type SARS-CoV-2 in independent assays. Anti-RBD MAbs were further grouped into four cross-inhibiting clusters, of which six antibodies from three separate clusters blocked the binding of RBD to ACE2 and five were neutralising. All ACE2-blocking anti-RBD antibodies were isolated from two recovered patients with prolonged fever, which is compatible with substantial ACE2-blocking response in their sera. Finally, the identification of non-competing pairs of neutralising antibodies would offer potential templates for the development of prophylactic and therapeutic agents against SARS-CoV-2.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009352&type=printable
spellingShingle Kuan-Ying A Huang
Tiong Kit Tan
Ting-Hua Chen
Chung-Guei Huang
Ruth Harvey
Saira Hussain
Cheng-Pin Chen
Adam Harding
Javier Gilbert-Jaramillo
Xu Liu
Michael Knight
Lisa Schimanski
Shin-Ru Shih
Yi-Chun Lin
Chien-Yu Cheng
Shu-Hsing Cheng
Yhu-Chering Huang
Tzou-Yien Lin
Jia-Tsrong Jan
Che Ma
William James
Rodney S Daniels
John W McCauley
Pramila Rijal
Alain R Townsend
Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
PLoS Pathogens
title Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
title_full Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
title_fullStr Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
title_full_unstemmed Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
title_short Breadth and function of antibody response to acute SARS-CoV-2 infection in humans.
title_sort breadth and function of antibody response to acute sars cov 2 infection in humans
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1009352&type=printable
work_keys_str_mv AT kuanyingahuang breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT tiongkittan breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT tinghuachen breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT chunggueihuang breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT ruthharvey breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT sairahussain breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT chengpinchen breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT adamharding breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT javiergilbertjaramillo breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT xuliu breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT michaelknight breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT lisaschimanski breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT shinrushih breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT yichunlin breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT chienyucheng breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT shuhsingcheng breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT yhucheringhuang breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT tzouyienlin breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT jiatsrongjan breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT chema breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT williamjames breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT rodneysdaniels breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT johnwmccauley breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT pramilarijal breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans
AT alainrtownsend breadthandfunctionofantibodyresponsetoacutesarscov2infectioninhumans